BioSpace News Archive

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has launched Phytonadione Tablets.

Alcyone Lifesciences, Inc., a leader in disease modifying therapies for the central nervous system (CNS) through its Advanced Precision Delivery Platforms, announced a presentation on its intrathecal delivery technology platform that has the potential to impact several CNS gene therapies and their development.

Cardiome Pharma Corp. Becomes Correvio Pharma Corp., Closes on $25.5 million (CAD) in Non-Dilutive Capital

Cipher Pharmaceuticals Inc. (TSX:CPH) today announced it has completed its previously announced acquisition of Cardiome Pharma Corp.

The VIVASCOPE System is an industry-leading reflectance confocal microscopy device that allows dermatologists to non-invasively visualize cellular structures within the skin.

Therapeutic soft lens designed to deliver pain and anti-infection drugs more evenly over time - replacing messy, less effective drops

Company recorded $1.5 million in revenue in the first quarter of 2018 compared with $1.7 million in revenue in the first quarter of 2017.

Late-Breaking Oral Presentations on AR101 Phase 3 PALISADE Results in Peanut-Allergic Children and Adults and on European Study of Psychosocial Impact of Peanut Allergy

Dr. Levin Brings More Than 35 Years of Biomedical Engineering and Cardiac Expertise to the Company

Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the “Company”) announced today financial and operational results for the three months ended March 31, 2018 and provided an overview of the Company’s recent corporate progress.